BIO CEO: Presenter Resource Center

  • Recommend
  • Tweet
  • Print
  • Email

Deadlines   |   Presenter Toolkit   |   Registration Instructions   |   Media Toolkit

About Company Presentations

The 14th Annual BIO CEO & Investor Conference features presentations by over 130 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations. Last year we not only scheduled over 1200+ Partnering Meetings, but also opened additional company presentation slots as we were sold out weeks before the conference!

Presenting Companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, who typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. The typical audience for a company presentation features public and private equity investors, as well as industry analysts, investment bankers and senior biotechnology executives.

If you've been invited to present, confirm your presentation early to guarantee your spot! We are also accepting applications, - submit one today!


Upcoming Deadlines

  • Early-Rate Registration Discount: December 15th, 2011
  • Partnering Profile Due: January 9th, 2012
  • The Waldorf Room Discount: January 13th, 2012
    • $289/night +tax - See details here.
  • Investor Kits to Arrive By: January 27th, 2012
  • Sign-Up for Webcasting: February 10th, 2012
     

Presenter Toolkit

More information coming soon. Check back for the following items:

  • Presenter Checklist:
    Important deadlines regarding your presentation and Partnering.
  • Presentation Details & Guidelines:
    Logistics to ensure your presentation goes smoothly.
  • Webcasting Information:
    Those interested will have the option of webcasting their presentation for an additional fee. Place your order here. Early Bird Registration for webcasting ends February 10th.
  • Speaker Release Form:
    Please sign if you would like your presentation to be available to registered attendees post-conference. To be available soon.
  • Investor Kits:
    All Investor Kits should be shipped to BIO's headquarters and not the Waldorf=Astoria. Please email sbehan@bio.org to notify us that you will be sending materials. You will then receive a shipping form. All materials must arrive at BIO's headquarters by January 27th. We cannot guarantee their display if shipped directly to The Waldorf.
  • BIO CEO & Investor Conference Presentation Title Slide:
    Download the BIO CEO PowerPoint template to use for your presentation.
     

Registration Instructions

Presenters can choose from two Registration Packages for the event.

The Presenter Group Package includes all presentation and registration fees for three people.

The Individual Registration option allows you to register your Presenter and pay your company's presentation fee. It allow allows for one additional registration (separate fee applies).

ALL presenters must be issued codes in order to begin Registration. Those who have confirmed their presentation should email their package selection and number of attendees to sbehan@bio.org.

Other registration questions? Find registration options for investors and other companies and organizations here.
 

Media Toolkit

More information coming soon. Check back for the following items:

Coverage at Last Year's Event

The BIO CEO & Investor Conference is a must-attend event for reporters covering the business of biotech and remains a widely-publicized event in the media. Last year’s event generated more than 50 million media impressions and attracted nearly 60 reporters.

Numerous top tier and trade outlets typically cover the event, including BioWorld, Bloomberg, CNBC, Fierce Biotech, In Vivo, Pink Sheet, Reuters, and The Street. Additionally, numerous reporters attend the event to identify future story opportunities. Outlets that attended last year included Chain Drug Review, Chemical & Engineering News, Dow Jones, Merger Market, Forbes, Nature Biotechnology, PharmaWire, The Deal and the Wall Street Journal.

Coverage focused on the overall state-of-the-industry, policy issues, business development, and company news. Headlines from the 2011 event included the following:

  • Medicago to present at the 13th annual BIO CEO & Investor Conference, MarketWatch, February 10, 2011
  • Study shows overall success rate of FDA drug approval from 2003 to 2010 is near one in ten, The Medical News, February 14, 2011
  • Geron to present at 13th annual BIO CEO & Investor Conference, Wall Street Journal, February 15, 2011
  • New study showing investors optimistic on biotech’s future, Industry Risk (risckcenter.com), February 15, 2011
  • Research examines drugs’ odds of getting FDA approval, SmartBrief, February 15, 2011
  • Outlook 2011 for US biotech: a boat load of optimism, but with caveats, Scrip, February 17, 2011
  • Investors say biotech indices will be up in 2011, may outperform health care sector, Life Sciences Law & Industry, February 25, 2011